Christopher J. Lindop, CFO & VP, Business Development at HAEMONETICS CORP (HAE), bought 264 shares at $49.83 ($13K) on 2012-05-01, disclosed to the SEC on 2012-05-03.
Seasonal purchase ($13k) by CFO & VP, Business Development — this insider has traded HAE in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| HAE | SELL | 2015-08-24 | $189K | — | Filing → |
| HAE | SELL | 2015-07-21 | $192K | — | Filing → |
| HAE | SELL | 2015-06-23 | $208K | — | Filing → |